Literature DB >> 21321212

Loss of cerebral cavernous malformation 3 (Ccm3) in neuroglia leads to CCM and vascular pathology.

Angeliki Louvi1, Leiling Chen, Aimee M Two, Haifeng Zhang, Wang Min, Murat Günel.   

Abstract

Communication between neural cells and the vasculature is integral to the proper development and later function of the central nervous system. A mechanistic understanding of the interactions between components of the neurovascular unit has implications for various disorders, including cerebral cavernous malformations (CCMs) in which focal vascular lesions form throughout the central nervous system. Loss of function mutations in three genes with proven endothelial cell autonomous roles, CCM1/krev1 interaction trapped gene 1, CCM2, and CCM3/programmed cell death 10, cause familial CCM. By using neural specific conditional mouse mutants, we show that Ccm3 has both neural cell autonomous and nonautonomous functions. Gfap- or Emx1-Cre-mediated Ccm3 neural deletion leads to increased proliferation, increased survival, and activation of astrocytes through cell autonomous mechanisms involving activated Akt signaling. In addition, loss of neural CCM3 results in a vascular phenotype characterized by diffusely dilated and simplified cerebral vasculature along with formation of multiple vascular lesions that closely resemble human cavernomas through cell nonautonomous mechanisms. RNA sequencing of the vascular lesions shows abundant expression of molecules involved in cytoskeletal remodeling, including protein kinase A and Rho-GTPase signaling. Our findings implicate neural cells in the pathogenesis of CCMs, showing the importance of this pathway in neural/vascular interactions within the neurovascular unit.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21321212      PMCID: PMC3048113          DOI: 10.1073/pnas.1012617108

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  50 in total

1.  Interaction between krit1 and icap1alpha infers perturbation of integrin beta1-mediated angiogenesis in the pathogenesis of cerebral cavernous malformation.

Authors:  J Zhang; R E Clatterbuck; D Rigamonti; D D Chang; H C Dietz
Journal:  Hum Mol Genet       Date:  2001-12-01       Impact factor: 6.150

Review 2.  Mechanisms, challenges and opportunities in stroke.

Authors:  Eng H Lo; Turgay Dalkara; Michael A Moskowitz
Journal:  Nat Rev Neurosci       Date:  2003-05       Impact factor: 34.870

3.  hGFAP-cre transgenic mice for manipulation of glial and neuronal function in vivo.

Authors:  L Zhuo; M Theis; I Alvarez-Maya; M Brenner; K Willecke; A Messing
Journal:  Genesis       Date:  2001-10       Impact factor: 2.487

4.  KRIT1 association with the integrin-binding protein ICAP-1: a new direction in the elucidation of cerebral cavernous malformations (CCM1) pathogenesis.

Authors:  Jon S Zawistowski; Ilya G Serebriiskii; Maximilian F Lee; Erica A Golemis; Douglas A Marchuk
Journal:  Hum Mol Genet       Date:  2002-02-15       Impact factor: 6.150

5.  A novel mouse model of cerebral cavernous malformations based on the two-hit mutation hypothesis recapitulates the human disease.

Authors:  David A McDonald; Robert Shenkar; Changbin Shi; Rebecca A Stockton; Amy L Akers; Melanie H Kucherlapati; Raju Kucherlapati; James Brainer; Mark H Ginsberg; Issam A Awad; Douglas A Marchuk
Journal:  Hum Mol Genet       Date:  2010-10-11       Impact factor: 6.150

6.  Accelerated hippocampal spreading depression and enhanced locomotory activity in mice with astrocyte-directed inactivation of connexin43.

Authors:  Martin Theis; Regina Jauch; Lang Zhuo; Dina Speidel; Anke Wallraff; Britta Döring; Christian Frisch; Goran Söhl; Barbara Teubner; Carsten Euwens; Joseph Huston; Christian Steinhäuser; Albee Messing; Uwe Heinemann; Klaus Willecke
Journal:  J Neurosci       Date:  2003-02-01       Impact factor: 6.167

7.  PDCD10, the gene mutated in cerebral cavernous malformation 3, is expressed in the neurovascular unit.

Authors:  Gamze Tanriover; Arianne J Boylan; Michael L Diluna; Katie L Pricola; Angeliki Louvi; Murat Gunel
Journal:  Neurosurgery       Date:  2008-04       Impact factor: 4.654

8.  Ccm1 is required for arterial morphogenesis: implications for the etiology of human cavernous malformations.

Authors:  Kevin J Whitehead; Nicholas W Plummer; Jennifer A Adams; Douglas A Marchuk; Dean Y Li
Journal:  Development       Date:  2004-03       Impact factor: 6.868

9.  Cortical excitatory neurons and glia, but not GABAergic neurons, are produced in the Emx1-expressing lineage.

Authors:  Jessica A Gorski; Tiffany Talley; Mengsheng Qiu; Luis Puelles; John L R Rubenstein; Kevin R Jones
Journal:  J Neurosci       Date:  2002-08-01       Impact factor: 6.167

10.  KRIT1/cerebral cavernous malformation 1 protein localizes to vascular endothelium, astrocytes, and pyramidal cells of the adult human cerebral cortex.

Authors:  Ozlem Guzeloglu-Kayisli; Nduka M Amankulor; Jennifer Voorhees; Guven Luleci; Richard P Lifton; Murat Gunel
Journal:  Neurosurgery       Date:  2004-04       Impact factor: 4.654

View more
  52 in total

Review 1.  Recent advances in vascular development.

Authors:  Courtney K Domigan; M Luisa Iruela-Arispe
Journal:  Curr Opin Hematol       Date:  2012-05       Impact factor: 3.284

2.  Phosphorylation sites in the cerebral cavernous malformations complex.

Authors:  Jaehong Kim; Nicholas E Sherman; Jay W Fox; Mark H Ginsberg
Journal:  J Cell Sci       Date:  2011-12-01       Impact factor: 5.285

Review 3.  Cavernous angiomas: deconstructing a neurosurgical disease.

Authors:  Issam A Awad; Sean P Polster
Journal:  J Neurosurg       Date:  2019-07-01       Impact factor: 5.115

4.  CCM3/PDCD10 heterodimerizes with germinal center kinase III (GCKIII) proteins using a mechanism analogous to CCM3 homodimerization.

Authors:  Derek F Ceccarelli; Rob C Laister; Vikram Khipple Mulligan; Michelle J Kean; Marilyn Goudreault; Ian C Scott; W Brent Derry; Avijit Chakrabartty; Anne-Claude Gingras; Frank Sicheri
Journal:  J Biol Chem       Date:  2011-05-11       Impact factor: 5.157

Review 5.  Cerebrovascular disorders associated with genetic lesions.

Authors:  Philipp Karschnia; Sayoko Nishimura; Angeliki Louvi
Journal:  Cell Mol Life Sci       Date:  2018-10-16       Impact factor: 9.261

6.  PDCD10 (CCM3) regulates brain endothelial barrier integrity in cerebral cavernous malformation type 3: role of CCM3-ERK1/2-cortactin cross-talk.

Authors:  Svetlana M Stamatovic; Nikola Sladojevic; Richard F Keep; Anuska V Andjelkovic
Journal:  Acta Neuropathol       Date:  2015-09-18       Impact factor: 17.088

Review 7.  Signaling pathways and the cerebral cavernous malformations proteins: lessons from structural biology.

Authors:  Oriana S Fisher; Titus J Boggon
Journal:  Cell Mol Life Sci       Date:  2013-11-29       Impact factor: 9.261

Review 8.  Cerebral cavernous malformation is a vascular disease associated with activated RhoA signaling.

Authors:  Bryan T Richardson; Christopher F Dibble; Asya L Borikova; Gary L Johnson
Journal:  Biol Chem       Date:  2013-01       Impact factor: 3.915

9.  Cerebral Cavernous Malformations Develop Through Clonal Expansion of Mutant Endothelial Cells.

Authors:  Matthew R Detter; Daniel A Snellings; Douglas A Marchuk
Journal:  Circ Res       Date:  2018-10-26       Impact factor: 17.367

10.  Loss of endothelial programmed cell death 10 activates glioblastoma cells and promotes tumor growth.

Authors:  Yuan Zhu; Kai Zhao; Anja Prinz; Kathy Keyvani; Nicole Lambertz; Ilonka Kreitschmann-Andermahr; Ting Lei; Ulrich Sure
Journal:  Neuro Oncol       Date:  2015-08-08       Impact factor: 12.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.